福安药业：“头孢托仑匹酯颗粒”获得药品注册证书

Core Viewpoint - Fuan Pharmaceutical's subsidiary, Qingyutang Pharmaceutical, has received a drug registration certificate from the National Medical Products Administration for "Cefotaxime Granules," which is indicated for various infections caused by sensitive bacteria [1] Company Summary - Fuan Pharmaceutical's subsidiary, Qingyutang, is now authorized to market Cefotaxime Granules, expanding its product portfolio [1] - The drug is suitable for treating superficial and deep skin infections, lymphangitis, chronic pyoderma, and various respiratory and urinary tract infections [1] - Currently, there are two companies, including Qingyutang, that have passed the consistency evaluation for this drug [1]